BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND ATRX, P46100, ZNF-HX, XNP, XH2, SHS, SFM1, RAD54, MRXHF1, MGC2094, ATR2, 546
123 results:

  • 1. Atypical Spindle Cell/Pleomorphic Lipomatous Tumor With Sarcomatous Transformation: Clinicopathologic and Molecular Analysis of 4 Cases.
    Perret R; Charville GW; Alame M; Rebier F; Soubeyran I; Gross JM; Graham D; Green DC; Kerr DA; Khan WA; Cloutier JM
    Mod Pathol; 2024 Apr; 37(4):100454. PubMed ID: 38417627
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Ewing's sarcoma of central nervous system: a clinicopathological analysis of six cases].
    Yang QY; Li H; Liu C; Bao ML; Fan QH; Pan MH
    Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1249-1254. PubMed ID: 38058042
    [No Abstract]    [Full Text] [Related]  

  • 3. Malignant female genital tract smooth muscle tumors with adipocytic differentiation: A morphologic, immunohistochemical, MDM2 fluorescence in situ hybridization and molecular genetic study of 6 lipoleiomyosarcomas.
    Swanson AA; Michal M; Xing D; Dashti NK; Židlík V; Cheek-Norgan EH; Keeney ME; Keeney GL; Sukov WR; Gupta S; Nucci MR; Schoolmeester JK
    Hum Pathol; 2024 Jan; 143():24-32. PubMed ID: 38000678
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Alternative lengthening of telomeres: mechanism and the pathogenesis of cancer.
    Mori JO; Keegan J; Flynn RL; Heaphy CM
    J Clin Pathol; 2024 Jan; 77(2):82-86. PubMed ID: 37890990
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma.
    Liu W; Cheng H; Huang Z; Li Y; Zhang Y; Yang Y; Jin T; Sun Y; Deng Z; Zhang Q; Lou F; Cao S; Wang H; Niu X
    Mol Oncol; 2024 Apr; 18(4):939-955. PubMed ID: 37727135
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Osteosarcoma's genetic landscape painted by genes' mutations.
    Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
    Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis.
    Nirala BK; Yamamichi T; Yustein JT
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511127
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
    Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
    J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirus.
    Floyd W; Pierpoint M; Su C; Patel R; Luo L; Deland K; Wisdom AJ; Zhu D; Ma Y; DeWitt SB; Williams NT; Lazarides AL; Somarelli JA; Corcoran DL; Eward WC; Cardona DM; Kirsch DG
    J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37200088
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcoma.
    Cole KA; Ijaz H; Surrey LF; Santi M; Liu X; Minard CG; Maris JM; Voss S; Reid JM; Fox E; Weigel BJ
    Cancer; 2023 Jul; 129(14):2245-2255. PubMed ID: 37081608
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
    Liao X; Lai J; Lin J; Zhang D
    Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Emerging predictive biomarkers in the management of bone and soft tissue sarcomas.
    Haddox CL; Riedel RF
    Expert Rev Anticancer Ther; 2023 May; 23(5):495-502. PubMed ID: 37017995
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical Targeted Next-Generation Panel Sequencing Reveals
    Marinoff AE; Spurr LF; Fong C; Li YY; Forrest SJ; Ward A; Doan D; Corson L; Mauguen A; Pinto N; Maese L; Colace S; Macy ME; Kim A; Sabnis AJ; Applebaum MA; Laetsch TW; Glade-Bender J; Weiser DA; Anderson M; Crompton BD; Meyers P; Zehir A; MacConaill L; Lindeman N; Nowak JA; Ladanyi M; Church AJ; Cherniack AD; Shukla N; Janeway KA
    JCO Precis Oncol; 2023 Mar; 7():e2200334. PubMed ID: 36996377
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Mutation characteristics of osteosarcoma: a single center study of 64 cases using next-generation sequencing].
    Gao DL; Dong RF; Liu WF; Gong LH; Xu HR; Niu XH; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):370-375. PubMed ID: 36973198
    [No Abstract]    [Full Text] [Related]  

  • 15. A Clinicopathologic and Molecular Characterization of Uterine sarcomas Classified as Malignant PEComa.
    Anderson WJ; Dong F; Fletcher CDM; Hirsch MS; Nucci MR
    Am J Surg Pathol; 2023 May; 47(5):535-546. PubMed ID: 36856023
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association between hepatic angiosarcoma and end-stage renal disease: nationwide population-based evidence and enriched mutational signature of aristolochic acid exposure.
    Huang SC; Chang IY; Chang CJ; Liu H; Chen KH; Liu TT; Hsieh TY; Chuang HC; Chen CC; Lin IC; Ng KF; Huang HY; Chen TC
    J Pathol; 2023 Jun; 260(2):165-176. PubMed ID: 36815532
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis.
    Momeni-Boroujeni A; Yousefi E; Balakrishnan R; Riviere S; Kertowidjojo E; Hensley ML; Ladanyi M; Ellenson LH; Chiang S
    Mod Pathol; 2023 Apr; 36(4):100084. PubMed ID: 36788080
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Oesophageal glomus tumours: rare neoplasms with aggressive clinical behaviour.
    Birkness-Gartman JE; Wangsiricharoen S; Lazar AJ; Gross JM
    Histopathology; 2023 Jun; 82(7):1048-1055. PubMed ID: 36788021
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Dedifferentiated leiomyosarcoma of the uterus: a clinicopathologic and immunohistochemical analysis of 23 cases.
    Chapel DB; Maccio L; Bragantini E; Zannoni GF; Quade BJ; Parra-Herran C; Nucci MR
    Histopathology; 2023 May; 82(6):812-825. PubMed ID: 36704944
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor.
    Manavella DD; McNamara B; Harold J; Bellone S; Hartwich TMP; Yang-Hartwich Y; Mutlu L; Zipponi M; Demirkiran C; Verzosa MS; Altwerger G; Ratner E; Huang GS; Clark M; Andikyan V; Azodi M; Schwartz PE; Dottino PR; Choi J; Alexandrov LB; Buza N; Hui P; Santin AD
    Gynecol Oncol; 2023 Feb; 169():98-105. PubMed ID: 36525930
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.